Test Your Knowledge of Severe Hypoglycemia and Glucagon Rescue in Type 2 Diabetes
Reviewed by: HU Medical Review Board | Last reviewed: July 2026 | Last updated: July 2026
Severe hypoglycemia is often treated as a type 1 diabetes concern, but it is a real and under-addressed risk for many patients with type 2 diabetes, and current guidance has shifted on who should have rescue glucagon on hand. These 5 questions test risk recognition, prescribing indications, and rescue logistics. See how your clinical knowledge holds up.
Clinical Challenge
Among commonly used oral glucose-lowering agents, which class carries the highest risk of clinically significant hypoglycemia?
Clinical Challenge
According to the 2026 American Diabetes Association (ADA) Standards of Care, which patients should be prescribed glucagon?
Clinical Challenge
An older patient with type 2 diabetes on basal insulin and a sulfonylurea, with reduced renal function and recurrent lows, has no rescue plan. What is the most appropriate next step?
Clinical Challenge
Which statement best characterizes impaired awareness of hypoglycemia?
Clinical Challenge
The ADA notes that intranasal and ready-to-inject glucagon are preferred over reconstitutable injectable kits. What best explains this preference and the role of bystanders?